Prosecution Insights
Last updated: August 14, 2026

Elucid Bioimaging Inc.

6 pending office actions • 2 art units • 3 examiners • 0 of 6 (0%) have an AI response strategy ready

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (83%)
0
Medium (0%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (83%)
Double-patenting only1 (17%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
2
Business / Other
33% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SKIBINSKY, ANNA 3 39.0% +28.9%
AUGER, NOAH ANDREW 2 34.7% +40.8%
HARANDI, SIAMAK 1 90.8% +7.4%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18918308 STRUCTURED REPRESENTATIONS FOR INTERPRETABLE MACHINE LEARNING APPLICATIONS IN MEDICAL IMAGING HARANDI, SIAMAK

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18240190 SCREENING CANDIDATE DYSLIPIDEMIA AGENTS AUGER, NOAH ANDREW 99d overdue
18240206 SCREENING POTENTIAL SUBJECTS FOR ENROLLMENT IN DYSLIPIDEMIA THERAPY CLINICAL TRIALS AUGER, NOAH ANDREW
18113944 IN SILICO MODELING TO SIMULATE CARDIOVASCULAR MEDICAL THERAPY RESPONSE SKIBINSKY, ANNA
17838135 SYSTEMS AND METHODS FOR PATIENT-SPECIFIC THERAPEUTIC RECOMMENDATIONS FOR CARDIOVASCULAR DISEASE SKIBINSKY, ANNA
17693229 VIRTUAL TRANSCRIPTOMICS SKIBINSKY, ANNA

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18240190 SCREENING CANDIDATE DYSLIPIDEMIA AGENTS AUGER, NOAH ANDREW 99d overdue
18240206 SCREENING POTENTIAL SUBJECTS FOR ENROLLMENT IN DYSLIPIDEMIA THERAPY CLINICAL TRIALS AUGER, NOAH ANDREW
18113944 IN SILICO MODELING TO SIMULATE CARDIOVASCULAR MEDICAL THERAPY RESPONSE SKIBINSKY, ANNA
17838135 SYSTEMS AND METHODS FOR PATIENT-SPECIFIC THERAPEUTIC RECOMMENDATIONS FOR CARDIOVASCULAR DISEASE SKIBINSKY, ANNA
17693229 VIRTUAL TRANSCRIPTOMICS SKIBINSKY, ANNA

Top Art Units

Art UnitApps
1687 2
1635 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18918308 STRUCTURED REPRESENTATIONS FOR INTERPRETABLE MACHINE LEARNING APPLICATIONS IN MEDICAL IMAGING HARANDI, SIAMAK DP Non-Final OA Pending Oct 17, 2024
18240206 SCREENING POTENTIAL SUBJECTS FOR ENROLLMENT IN DYSLIPIDEMIA THERAPY CLINICAL TRIALS AUGER, NOAH ANDREW 1687 §101§103§112DPOther Final Rejection Pending Aug 30, 2023
18240190 SCREENING CANDIDATE DYSLIPIDEMIA AGENTS AUGER, NOAH ANDREW 1687 §101§103§112DP Final Rejection 99d overdue Pending Aug 30, 2023
18113944 IN SILICO MODELING TO SIMULATE CARDIOVASCULAR MEDICAL THERAPY RESPONSE SKIBINSKY, ANNA §101§103Other Non-Final OA Pending Feb 24, 2023
17838135 SYSTEMS AND METHODS FOR PATIENT-SPECIFIC THERAPEUTIC RECOMMENDATIONS FOR CARDIOVASCULAR DISEASE SKIBINSKY, ANNA 1635 §101§103§112 Non-Final OA Pending Jun 10, 2022
17693229 VIRTUAL TRANSCRIPTOMICS SKIBINSKY, ANNA 1635 §101§103§112 Non-Final OA Pending Mar 11, 2022

Managing Elucid Bioimaging Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month